Cardiovascular autonomic functions in

Epilepsy Research(2009)85,

261—269

j o u r n a l h o m e p a g e:w w w.e l s e v i e r.c o m/l o c a t e/e p i l e p s y r e

s

Cardiovascular autonomic functions in

well-controlled and intractable partial epilepsies Shalini Mukherjee a,Manjari Tripathi b,Poodipedi S.Chandra c,

Rajeev Yadav d,Navita Choudhary e,Rajesh Sagar f,Ra?a Bhore g,

Ravindra Mohan Pandey h,K.K.Deepak e,?

a Dept.of Neurology,UT Southwestern Medical Center at Dallas,5323Harry Hines Blvd,Dallas,TX,United States

b Dept.of Neurology,All India Institute of Medical Sciences,New Delhi110608,India

c Dept.of Neurosurgery,All India Institute of Medical Sciences,New Delhi110608,India

d Department of Electrical and Computer Engineering,Concordia University,Montreal,Canada

e Dept.o

f Physiology,All India Institute of Medical Sciences,New Delhi110608,India

f Dept.of Psychiatry,All India Institute of Medical Sciences,New Delhi110608,India

g Department of Clinical Sciences,UT Southwestern Medical Center at Dallas,5323Harry Hines Blvd,Dallas,TX,United States

h Dept.of Biostatistics,All India Institute of Medical Sciences,New Delhi110608,India

Received6March2008;received in revised form20March2009;accepted27March2009

Available online5May2009

KEYWORDS SUDEP

well-controlled epilepsy; Intractable; Autonomic tone; Inter-ictal; Dysautonomia Summary

Background:Epilepsy is associated with imbalance of sympathetic and parasympathetic activity which may lead to sudden unexplained death in epilepsy(SUDEP).Well-controlled(WcE)and intractable epilepsy(IE)subjects may present different autonomic pro?les,which can be helpful in explaining the predisposition of the latter to SUDEP.

Purpose:T o compare inter-ictal cardiovascular autonomic function in subjects with partial WcE and IE.

Methods:Thirty WcE and31IE subjects underwent a battery of autonomic function tests:deep breathing,Valsalva maneuver,isometric exercise,cold pressor and tilt-table.Autonomic tone was assessed by heart rate variability(HRV).Their autonomic severity score and anxiety status was also assessed.

?Corresponding author.T el.:+9101126593583/26594801/26594971(o)/01126164342(r);fax:+9126588663/26588789.

E-mail addresses:shalini mukherjee@https://www.360docs.net/doc/0611674472.html,(S.Mukherjee),manjari.tripathi@https://www.360docs.net/doc/0611674472.html,(M.Tripathi),saratpchandra@https://www.360docs.net/doc/0611674472.html, (P.S.Chandra),rajeevyadav@https://www.360docs.net/doc/0611674472.html,(R.Yadav),navitachoudhary@https://www.360docs.net/doc/0611674472.html,(N.Choudhary),rajeshsagar@https://www.360docs.net/doc/0611674472.html,(R.Sagar), ra?a.bhore@https://www.360docs.net/doc/0611674472.html,(R.Bhore),rmpandey@https://www.360docs.net/doc/0611674472.html,(R.M.Pandey),kkdeepak@https://www.360docs.net/doc/0611674472.html,(K.K.Deepak).

0920-1211/$—see front matter?2009Elsevier B.V.All rights reserved.

doi:10.1016/j.eplepsyres.2009.03.021

262S.Mukherjee et

al.

Results:IE subjects had elevated low frequency component(52.0vs.37.6,p=0.047)and decremented high frequency component(114vs.397,p=0.013)of HRV and higher diastolic BP(75.62±9.77vs.68.64±0.43,p=0.036).In deep breathing test,they had lesser HR changes (20±10.18vs.29.68±11.23,p=0.007)and lower E:I(1.29±0.16vs.1.43±0.21,p=0.008).IE subjects had higher dysautonomia(chi square165.0,p<0.0001).

Conclusions:We observed a higher vasomotor tone,higher sympathetic tone,lower parasympa-thetic tone,lower parasympathetic reactivity and more severe dysautonomia in the IE subjects. Refractoriness may lead to an alteration in cardiovascular autonomic regulation,which might be a predisposing factor for SUDEP.

?2009Elsevier B.V.All rights reserved.

Introduction

Seizures are frequently associated with autonomic symp-toms,which occur either during the seizure prodrome(aura) or as a predominant part of the seizure manifestation.The abnormal cortical activity underlying a seizure can involve central regions that regulate autonomic activity and present with autonomic symptoms,either initially or during its prop-agation.Seizure related hypo or hyperactivity modi?es the cardiovascular system.In many instances,there is tachy-cardia and pressor responses preceding or accompanying the seizure discharge,while bradyarrythmias and arterial hypotension are rare(Nashef et al.,1996;Devinsky et al., 1997;Leutmezer et al.,2003).Around a third of simple par-tial seizures and all generalized seizures are accompanied by autonomic symptoms(Nouri and Marshall,2006),although in partial seizures,autonomic symptoms often go undetected (Devinsky,2004).

Studies also suggest interictal autonomic disturbances, mostly showing enhanced sympathetic cardiovascular tone (Frysinger et al.,1993;Devinsky et al.,1994;Faustmann and Ganz,1994).Changes in parasympathetic heart rate modulation resulting in lower heart rate variability(HRV) have been noticed in temporal lobe epilepsies(Ansakorpi et al.,2000,2002,2004;Ronkainen et al.,2006)and general-ized epilepsies(Harnod et al.,2007;El-Sayed et al.,2007). Anti-epileptic drug therapy,speci?cally carbamezapine may also in?uence cardiovascular autonomic functions(T omson et al.,1998;Ansakorpi et al.,2000).

The mortality rate among people with epilepsy is2—3 times higher and the risk of sudden death is24times greater than in the general population(Ficker et al.,1998). Sudden unexplained death in epilepsy subjects(SUDEP) accounts for deaths in about2%of population based cohorts with epilepsy and in18—25%subjects with more severe intractable epilepsy(Walczak,2003).

The prevailing hypothesis regarding SUDEP involves seizure-induced cardio-respiratory disturbances mediated by the autonomic nervous system(Nashef et al.,1996; Rocamora et al.,2003).It has been proposed that imbalance of sympathetic and parasympathetic cardiovascular activity is a potential cause of SUDEP.It has also been postulated that reduced controls in autonomic nervous system in refrac-tory seizure disorders may be the likely cause for SUDEP (Massetani et al.,1997;Ansakorpi et al.,2000).Among the other causes,some studies have identi?ed anti-epileptic drug(AED)therapy,especially polytherapy as a risk factor independent of seizure control(Nilsson et al.,1999;Walczak et al.,2001;Walczak,2003),along with frequent dose changes and high serum concentrations of carbamazepine (Nilsson et al.,2001).Other studies have however,not been able to?nd any speci?c association between SUDEP and par-ticular AED therapy and hypothesized that SUDEP was linked more to the severity of epilepsy rather than AEDs(Leestma et al.,1997).

Keeping in mind the strong association between cardiovascular autonomic dysfunction and SUDEP and how the latter was linked to seizure severity, we wanted to study autonomic functions in sub-jects with intractable and well-controlled partial epilepsies.There is only one previous study,in which autonomic functions were compared between well con-trolled and intractable subjects with temporal lobe epilepsies(Ansakorpi et al.,2000).We hypothesized that the autonomic functions in subjects with intractable epilepsy would be different from those with well-controlled partial epilepsies,irrespective of localization of seizure foci.This is the?rst study in which heart rate variability, a complete battery of autonomic functions tests and neuropsychological questionnaires are used to compare autonomic and psychological status in subjects with refractory and well-controlled partial epilepsy.

Materials and methods

Subjects

The study was carried out in the Autonomic Function Lab in the Department of Physiology,All India Institute of Medical Sciences. Subjects were referred from the Out-Patient Departments of Neu-rology and Neurosurgery.All consecutive subjects who were treated by these departments in the age group between5and50years and con?rmed as having partial seizures,either wellcontrolled or intractable,were included in this observational study.Subjects were diagnosed as having medically intractable partial epilepsy if he has2or more disabling seizures per month,for2or more years,which is not controlled by2or more anti-epileptic drugs in their maximum tolerated doses(Radhakrishnan,1999).For the well-controlled group,only those subjects who were seizure-free for at least6months prior to the study were included.The study was approved by the Institutional Ethics committee and informed con-sent was obtained from subjects(or guardians in case of minors). Subjects with signs or symptoms other than epilepsy and suffering from diseases that are known to affect the autonomic nervous sys-tem(i.e.diabetes mellitus,cardiopulmonary disease,renal failure) were excluded from the study.Subjects with diagnosed psychiatric illness and with chronic alcoholism or smoking were also excluded.

Cardiovascular autonomic functions263

Their AED regimen was kept unchanged during the course of the study.Pregnant women were not included.

Study conditions

Subjects underwent a battery of tests to assess autonomic reac-tivity.The IE subjects were tested,in almost all cases,during hospitalization prior to epilepsy surgery.Considering the possibility that the results may be affected by anxiety of surgery and hospital-ization,we carried out detailed neuropsychological questionnaires in both groups.

Subjects were advised to refrain from food and beverages(other than water)for2h before the test and to only take their regular dose of AEDs before the test.All the tests were carried out in an air-conditioned laboratory environment(22±2?C)in supine positions for head up tilt and HRV and sitting positions for the other reactivity tests.They were carried out between9a.m.and4p.m.and the total duration of the tests was2.5—3h.Cardiovascular autonomic reactivity was tested using a standard battery of tests,as described previously(Ewing and Clarke,1982;Deepak et al.,1996).Heart rate responses during deep breathing test,Valsalva maneuver and head up tilt were noted as markers of parasympathetic reactivity,while blood pressure responses during cold pressor test,isometric hand-grip test and head up tilt were studied as markers of sympathetic reactivity.We also measured cardiovascular autonomic tone in the two groups,by means of5min supine electrocardiograph(ECG)to analyze HRV.

Baseline measurements

We used a standard polyrite(Recorders and Medicare,India)to trace heart rate and respiration.ECG recordings were taken using the Lead II con?guration and respiration was recorded using a chest stethograph.Resting BP(by standard mercury sphygmomanometer), heart rate and respiratory rate were estimated after the patient was rested for at least15min.Continuous ECG and respiratory tracings were obtained during the reactivity tests.Adequate time was given between each test for the blood pressure and heart rate to come back to normal levels.The following tests were performed in the order described.

Deep breathing test

Subjects were asked to breathe at6breath/min with equal inspi-ratory/expiratory cycles,each of5s.E:I ratio was calculated by dividing the average of the maximum RR interval(RRI)and aver-age of the minimum RRI;the difference between the maximum and minimum heart rate(HR)gave the HR.

Valsalva maneuver

Subjects were trained to blow into a mouthpiece with a tubing to a mercury manometer and maintain a pressure of40mm Hg,for 15s.Care was taken to see that this was a forced expiration from the chest,with an open glottis and the procedure was repeated if necessary.We calculated the Valsalva ratio(VR)from the maximum RRI in stage IV divided by the minimum RRI in stage II.T achycar-dia ratio(TR)and bradycardia ratio was calculated by dividing the maximum HR in stage II and minimum HR in stage IV by basal HR respectively.The maximum and minimum HR during the procedure was calculated.

Sustained hand grip test

Subjects were asked to maximally contract a handgrip dynamome-ter(Jetter and Scheerer,Germany)using their dominant hand and the maximum voluntary contraction(MVC)was calculated.He/she was then asked to press the dynamometer at30%MVC for up to 4min or as long as sustainable(in children).BP was measured before,and after contraction at1,2and4min,in the contra-lateral arm.

Cold pressor test

Subjects were asked to dip their hand into ice cold water(10?C) for1min.Changes in BP and HR were monitored as baseline,and at1min,before retracting the hand.The maximum increases in systolic and diastolic pressure were noted.

Head up tilt test

Subjects were rested on a mechanical tilt table and tilted to70?in 15s.An ECG was recorded continuously while BP was recorded inter-mittently during a5min tilt.BP was measured at baseline,0.5min, 1min,and2.5min and at5min during the tilting procedure.The ratio between the longest RRI at around30th beat to the shortest RRI at around15th beat was calculated as the30:15ratio.

Test for cardiovascular tone

The patient was rested comfortably for at least15min in a silent, dimly lit,electromagnetically shielded room—after which res-piration and ECG waveforms were recorded for5min.HRV was assessed following established guidelines(CCTILAE,1989).Signals were acquired using BIOPAC MP150(BIOPAC,USA)system and Acqknowledge3.5software.ECG was recorded in the Lead II con?g-uration and collected via the ECG ampli?er module.The signal was sampled at1000Hz,using a50Hz notch?lter and35Hz(low pass) and0.05Hz(high pass)?lters.Analysis was carried out using MAT-LAB v6.5(MathWorks Inc.,Japan).Raw digital signal from Biopac was pruned to ASCII.After acquisition,the ECG was?ltered using 5th order Butterworth IIR?lter with a cutoff frequency of3Hz and 20Hz.

We developed a novel R-peak detection algorithm using the nonlinear frequency-weighted energy(FWE)operator,to?nd the R-peaks of the QRS complex(Plotkin and Swamy,1992;Agarwal et al.,1996;Yadav et al.,2007).Quantitative time domain analysis was performed on normal—normal(NN or RR)interval,and mean, SDNN(standard deviation of NN intervals),SDSD(standard devia-tion of successive NN differences),RMSSD(square root of the mean squared difference of the consecutive NN intervals),NN50(num-ber of pairs of adjacent NN intervals differing by more than50ms), and pNN50(proportion of NN intervals differing more than50ms to the total number of NN intervals)were computed.Both parametric and nonparametric spectral analysis were performed to estimate the power of the contributing frequencies in the R—R wave.Prior to spectral analysis,R—R wave was cubic spline interpolated at4Hz, a Welch power spectral density(PSD)was calculated,and the val-ues were normalized.The PSD was estimated in three frequency bands of very low frequency(VLF,0.001—0.04Hz),low frequency (LF,0.040—0.15Hz)and high frequency(HF,0.15—0.4Hz)(Akselrod et al.,1981).The spectral estimates of respiration were also car-ried out using Welch FFT and autoregressive(AR)power spectral density;the latter gave the best results with an order of10. Neuropsychological evaluation

At the end of the study,we administered three different investigator-rated questionnaires to assess the anxiety of the patient.The Hamilton Anxiety Scale(Hamilton,1959),covering the whole range of anxiety neurosis,has14test items,each having a maximum score of4;yielding a total maximum score of56points. The Clinical Anxiety Scale(Snaith et al.,1982),derived from the Hamilton anxiety scale is mostly con?ned to psychic anxiety and tension in the somatic musculature.There are7items,each hav-ing a maximum score of4and total maximum score of24points. The Brief Scale of Anxiety(Tyrer et al.,1984)is a subdivision of the comprehensive Psychopathophysiological Rating Scale and is help-ful in assessing mixed states of anxiety.There are10items with a

264S.Mukherjee et al.

Table1Demographics of the study groups.

No.of patients Age Seizure free since Refractory since Well controlled

Male1818.67±9.09 2.12—

Female1219.83±8.12 2.24—

T otal3019.13±8.72 2.18—

Intractable

Male2221.95±11.54—13.09

Female922.44±6.25—11.55

T otal3122.11±10.18—12.64

maximum score of6given to any one item;total maximum score is 24.

Autonomic symptom score

A detailed history of autonomic symptoms were taken and the subjects were scored on presence/absence of the following symptoms:nasal stuf?ness/dryness;excessive/loss of sweating response;postural fall/dizziness;gastrointestinal disturbances like diarrhea/constipation/pain in the abdomen;vascular headache (heaviness in head/throbbing headache/migraine);micturition dis-turbances,occasional attack of bronchospasm,i.e.after exercise, laughter or emotion;abnormal sensation of warmth/cold all over the body and abnormal warm/cold sensation in the extremities.A total of9items were scored as either1(presence)or0(absence) of symptoms.

We also devised an autonomic severity score,in which7indices of autonomic function(E:I. HR,VR,30:15ratio, rise in diastolic BP in cold pressor test, rise in diastolic BP in hand grip test and fall in systolic BP in head up tilt)were considered.A normal score was counted as0,borderline as1and abnormal scores as 2.Normal autonomic functions were designated a total score of0; mild autonomic neuropathy:1—4;moderate autonomic neuropathy: 5—8and severe autonomic neuropathy:9—14points(Deepak et al., 1996).

Data processing and statistical analysis

Descriptive statistics for all analyzed factors were computed as mean±standard deviation,except for HRV,which are expressed as median and range.The distribution of the data was deter-mined using the Kolmogorov—Smirnov and Shapiro—Wilk tests for normality.In the case of those parameters where normality assump-tion was met,two-way analysis of variance(ANOVA)models were used to compare autonomic parameters,anxiety scores and auto-nomic symptom scores.This was done between the group of well-controlled epilepsy(WcE)subjects vs.intractable epilepsy(IE) subjects after adjusting for the second factor of AED use(with vs. without carbamazepine or CBZ therapy).Gender and age were not included as factors in these models,since the small sample size in each category did not afford enough statistical power to do so.A test for interaction(if any)between group and drug use was also included in the two-way ANOVA model.In those parameters like HRV where normality assumptions were not met,a Friedman’s two-way test(nonparametric analog to ANOVA)was used.Autonomic severity scores were analyzed by Pearson’s chi square test of independence. The data was analyzed by using the SAS version9.1.3.A two-sided p-value,p<0.05,was considered signi?cant for all statistical tests.Results

The demographics of the subjects are shown in T able1and the list of AEDs taken are shown in T able2.In the WcE group, 26subjects were stable on1AED,while4were on2AEDs. Seventeen subjects were on CBZ either alone(16)or in com-bination(1)with another AED.In the IE group,25subjects were on2AEDs while5were on3AEDs;24subjects were on CBZ in combination with other drugs.

T wo-way ANOVA models(or the nonparametric analog of ANOVA,namely,Friedman’s test)comparing the vari-ous parameters studied(resting autonomic variables,tests for sympathetic and parasympathetic reactivity,HRV,auto-nomic and neuropsychological scores)between the two disease groups(WcE and IE),after adjusting for the main effect of anti-epileptic drug use(with or without CBZ)and group by drug-use interaction effect showed that there was no statistically signi?cant two-way interaction between groups and drug use.The p values for the group by drug inter-Table2Anti-epileptic medications taken by the study groups.

Anti-epileptic drugs(AEDs)Well controlled Intractable

CBZ16—

CBZ+CLO—6

CBZ+DPH11

CBZ+LRE—4

CBZ+PB—1

CBZ+TPA—1

CBZ+VPA—6

CBZ+VPA+DPH—1

CBZ+VPA+LRE—3

CBZ+VPA+TPA—1

DBH+CLO1—

DPH2—

VPA81

VPA+CLO—1

VPA+LRE23

VPA+TPA—2 Abbreviations:CBZ,carbamezapine;CLO,clobazam;DPH, phenytoin;LRE,lamotrigine;PB,phenobarbital;TPA,topira-mate;VPA,valproate.

Cardiovascular autonomic functions265

Table3Resting autonomic parameters in the study groups.

Parameters Well controlled(N=30)(mean±SD)Intractable(N=31)(mean±SD)p-Value SBP(mm Hg)110.07±11.86115.79±10.380.145 DBP(mm Hg)68.64±.4375.62±9.770.036 HR(bpm)85.36±16.9581.43±12.650.560 RR(cpm)17.5±3.5519.43±3.530.054 Results were obtained by a two-way ANOVA model for the two groups,adjusting for AED use(with/without CBZ).As there was no evidence of interaction due to AED,the group differences alone are shown.Abbreviations:SBP,systolic blood pressure;DBP,diastolic blood pressure;HR,heart rate;RR,respiratory rate.

action effect ranged from minimum p=0.06(for NN50)to maximum p=0.91(for VR).In other words,in this study the magnitude of difference in autonomic parameters between WcE and IE subjects was the same regardless of whether they used CBZ or not.Hence,the results described below are those obtained from ANOVA model examining the main effect of groups and the main effect of drug use.The p val-ues for drug use(CBZ vs.no CBZ)ranged from minimum p=0.11(for HR)to maximum p=0.96(for rise in SYSTOLIC BP with hand grip test).Thus,there was no signi?cant dif-ference in the parameters studied between subjects using CBZ or no CBZ therapy.

Resting parameters

The WcE subjects had a signi?cantly lower diastolic BP during resting conditions without concurrent change in HR (p=0.036;T able3);this was also observed in the resting conditions at multiple testing levels.

Sympathetic reactivity tests

T wenty-eight subjects in the WcE group and27subjects in IE group performed all the reactivity tests.In response to the hand grip test and cold pressor test,there was no signi?cant rise in diastolic BP(p=0.604;T able4);similarly the fall in systolic BP was not different in the two groups in response to head up tilt test(p=0.682;T able4). Parasympathetic reactivity tests

Five subjects(3of IE and2of WcE)were unable to follow the instructions and the deep breathing test was repeated. In the deep breathing test,the rise in HR and the

Table4T ests to measure autonomic reactivity in the study groups.

Variable Well controlled(N=28)(mean±SD)Intractable(N=27)(mean±SD)p-Value T ests for sympathetic reactivity

Hand grip test

Basal DBP75.79±8.8581.29±10.070.026 Rise in DBP20.85±7.7819.85±8.280.604 Cold pressor test

Basal DBP78±8.1380.93±9.620.678 Rise in DBP15.70±8.4315.46±8.860.934 Head up tilt

Basal SBP109.79±12.57115.04±9.740.275 Fall in SBP 3.71±3.99 4.37±4.190.682 T ests for parasympathetic reactivity

Deep breathing

HR29.68±11.2320±10.180.007 E:I 1.43±0.21 1.29±0.160.008 Valsalva maneuver

VR 1.93±0.43 1.87±0.460.890 TR 1.42±0.3 1.30±0.150.241 BR0.75±0.140.74±0.140.5841 Head up tilt

30:15ratio 1.22±0.36 1.11±0.080.686 Results were obtained by a two-way ANOVA model for the two groups,adjusting for AED use(with/without CBZ).As there was no evidence of interaction due to AED,the group differences alone are shown.Abbreviations:SBP,systolic blood pressure;DBP,diastolic blood pressure;E:I,expiratory/inspiratory ratio;VR,valsalva ratio;TR,tachycardia ratio;BR,bradycardia ratio;30:15,ratio of the RRI of the30th beat to the15th beat after tilt at70?.

266S.Mukherjee et al.

Table5Comparison of heart rate variability-frequency and time domain measures.

Variable Well controlled(N=30)median and range Intractable(N=31)median and range p-Value Frequency domain measures

VLF(ms2)275.14(33.99—2073.32)307.01(28.88—1769.06)0.529 LF(ms2)141.5(19—1496)297(6—3623)0.078 LF(nu)37.6(8.1—74)51.15(20—83.2)0.048 HF(ms2)397(3—1793)114(10—999)0.013 HF(nu)36.3(4.6—80.5)33.15(12.5—75.1)0.308 LF/HF 1.15(0.21—4.04) 1.92(0.27—6.64)0.075 Time domain measures

SDNN26.71(4.34—68.61)22.11(3.26—78.44)0.435 SDSD35.62(6.35—132.86)29.95(3.87—148.06)0.423 RMSSD35.58(6.34—132.69)29.91(3.87—147.88)0.423 NN5015.95(3.9—23.4)11.0(1.5—22.1)0.033 pNN50 3.89(0.75—5.9) 2.69(0.31—5.3)0.034 Results were obtained by a two-way ANOVA model for the two groups,adjusting for AED use(with/without CBZ).As there was no evidence of interaction due to AED,the group differences alone are shown.Frequency domain measures:VLF,very low frequency; LF,low frequency;HF,high frequency,frequencies described in ms2or normalized units(nu).Time domain measures:SDNN,standard deviation of NN intervals;SDSD,standard deviation of successive NN differences;RMSSD,square root of the mean squared difference of the consecutive NN intervals;NN50,number of pairs of adjacent NN intervals differing by more than50ms;pNN50,proportion of NN intervals differing more than50ms to the total number of NN intervals.

Table6Comparison of autonomic symptoms and neuropsychological scores.

Variable Well controlled(N=30)(mean±SD)Intractable(N=20)(mean±SD)p-Value Autonomic symptom score 2.38±1.89 2.31±1.490.885 Hamilton’s anxiety score9.25±5.979.33±3.00.95 Clinical scale of anxiety4±2.837.44±5.830.061 Brief Scale of anxiety 2.75±1.5 6.67±3.580.018 Results were obtained by a two-way ANOVA model for the two groups,adjusting for AED use(with/without CBZ).As there was no evidence of interaction due to AED,the group differences alone are shown.

E:I ratio was signi?cantly lower in IE than WcE subjects (p=0.007for HR and p=0.008for E:I ratio;T able4). The other measures from Valsalva maneuver and the30:15 ratios were not signi?cantly different between the two groups.

Heart rate variability(HRV)measures

Low frequency(LFnu)component was signi?cantly higher (p=0.078and p=0.048),and HF was signi?cantly lower (p=0.013and p=0.308)in the IE than the WcE group. This means that IE subjects had a higher sympathetic drive to the myocardium.However,in time domain measures,IE subjects exhibited a trend towards lower values,of which only NN50and pNN50were reached signi?cance. This shows that the parasympathetic drive to the heart was lower in IE than WcE subjects(T ask Force,1996) (T able5).

There were no signi?cant differences in anxiety ques-tionnaires(T able6)except in the brief anxiety scores (WcE2.75±1.5vs.IE6.67±3.58,p=0.018).Subjects were not different in terms of reported autonomic symptoms. However,autonomic dysfunctions were more severe in IE subjects,as was evident from their autonomic severity scores(T able7).In the WcE group,9/28(32.48%)had mild, 3/28(10.71%)had moderate and1/28(3.57%)had severe autonomic neuropathy.In comparison,the IE subjects,14/27

Table7Chi square distribution of autonomic severity.

Normal Mild Moderate Severe T otal Chi square p-Value Well controlled1494128165.0<0.0001 Intractable7146027

T otal212310155

Pearson’s chi square test of independence,p<0.001.

Cardiovascular autonomic functions267

(51.85%)had mild and6/27(22.23%)had moderate auto-nomic neuropathy(p<0.0001).

Discussion

We found a higher sympathetic and a lower parasympathetic tone in HRV,along with lower parasympathetic reactivity in subjects with intractable epilepsy,when compared to subjects whose epilepsy was controlled with medication.

A difference was also noted in the baseline sympathovagal tone,which was higher in those refractory to treatment. Overall,the degree of autonomic severity was signi?cantly higher in the IE subjects.On the basis of our?ndings,we conclude that subjects with recurrent seizures have a dif-ferent autonomic pro?le from those who are seizure free for a considerable amount of time.

Previously,there has been only one study which com-pared the autonomic pro?les in subjects with well controlled and intractable epilepsies of the temporal lobe(Ansakorpi et al.,2000).Our results are similar in that we found no differences in sympathetic reactivity in the two groups. We had,however,also incorporated an additional test for sympathetic reactivity(cold pressor test),which makes our study more robust.A recent study(Sathyaprabha et al., 2006)observed a severe loss of sympathetic as well as parasympathetic reactivity in73chronic intractable epilep-tic subjects,when compared to age and sex matched healthy controls.The main difference between our study and the former is the comparison with healthy controls vis-à-vis with well-controlled epilepsy subjects(our case),whose auto-nomic functions are already compromised.Also,subjects with generalized epilepsies have more severe autonomic dysfunctions and a heterogeneous group of partial and gen-eralized refractory epilepsies would re?ect more severe dysautonomia when compared to healthy controls.Many previous studies have shown that epilepsy subjects have signi?cant autonomic dysfunctions when compared to con-trols and the dysfunction is correlated to seizure severity (Faustmann and Ganz,1994;T omson et al.,1998;Devinsky et al.,1994).

Many factors may contribute to explain the differences that we observed between the two groups:they could arise from differences in seizure severity,different anatomical localizations of the seizure foci,as well as the effect of anti-epileptic drugs(AEDs).Several studies indicate that AEDs like CBZ are signi?cantly associated with autonomic dysfunc-tion in epileptic subjects(Devinsky et al.,1994;Isojarvi et al.,1998;Persson et al.,2003).In our study,56.67%of sub-jects in the WcE group and77.42%of those in the IE group were on CBZ—either alone or in combination with other AEDs.However in our study,when we analyzed the data with respect to CBZ use in the two groups,no signi?cant interac-tion was evident.Hence,the dysautonomia in the IE group was present irrespective of CBZ regimen.Localization of the seizure foci may also be directly associated with autonomic dysfunction,since structures like the amygdala and the insu-lar cortex plays an important role in modulating heart rate (Cechetto,2000;King et al.,1997).Furthermore,severity of autonomic dysfunction is also seen to depend on the volume of cerebral structures recruited in a seizure(Epstein et al., 1992).

We observed higher baseline BP in IE subjects at multiple testing levels without any concomitant changes in HR,signifying a higher vasomotor tone.This may be due to either baroreceptor abnormalities or inter-ference of seizure activity on central neurons involved in baroreceptor modulation,resulting in a continuous baseline activation of vasomotor neurons.In a seizure model using pentylenetetrazole-treated rats,Kanter et al. (1995)observed seizure-induced neuronal activation and demonstrated that central neurons involved in barore?ex modulation are activated directly by seizure discharge,and not in response to seizure associated hypertension.Barore-?ex sensitivity was seen to be lower in refractory TLE subjects and improve after resective surgery(Hilz et al., 2002).

We compared IE subjects who were hospitalized for resective surgery,with WcE subjects.In order to?nd out whether anxiety could be a factor in in?uencing our results, we carried out detailed neuropsychological questionnaires in both groups.Our data did not show any differences between the groups,except a rise in scores in the Brief Scale of anxiety questionnaire.It is important to remember that this scale can also rate pathological anxiety in the setting of a concomitant medical or neurological disorder.The IE sub-jects are more severely affected by epilepsy than the WC group,which may explain the increased scores.However, the actual scores(6.67±3.58out of24)show only a mild anxiety response.

This study brings to light some important?ndings.Our results corroborate previous studies which concluded that degree of autonomic abnormalities may be related to seizure severity(Nashef et al.,1998;Nilsson et al.,1999;Walczak et al.,2001;Ansakorpi et al.,2002;Persson et al.,2005).We also found IE subjects to have higher sympathetic activation, lower parasympathetic function and higher sympathovagal tone when compared to WcE subjects,which has not previ-ously been reported.Higher sympathetic function and lower parasympathetic function has been demonstrated to be sig-ni?cant risk factors for SUDEP.We also report this study in a young cohort of intractable epilepsy subjects,where the average age was21.24years.This is especially important in the context of altered cardiovascular autonomic functions, which may predispose them to SUDEP.When we compare the dysautonomic symptoms,we do not see marked differences in the severity of symptoms in the two groups.However,the total number of patients with some sort of autonomic dys-function(mild,moderate and severe)was higher in the IE subjects(20/27or75%)than in the WcE subjects(14/28or 50%).

As in any observational study with a small sample size, this study too has certain limitations.We were unable to consider the effects of factors such as age,gender and multidrug therapy in our analysis,due to sample size constraints.The IE group had more male subjects when com-pared to those in the WcE group,and the effect of these gender differences on the results cannot be accounted for in this study.This was also a heterogeneous sample with respect to localization of the seizure foci and AED regimen. In the future,a prospective,randomized trial in subjects with homogenous foci followed over time may help further elucidate the role of dysautonomia in epilepsy and the com-plex association with SUDEP.

268S.Mukherjee et al.

We conclude that WcE and IE subjects have differ-ent autonomic pro?les.The decrease in parasympathetic reactivity,increase in vasomotor tone and sympathetic acti-vation and overall higher degree of dysautonomia in IE subjects may increase their risk of cardiovascular emergen-cies and SUDEP.

Acknowledgment

The author was funded by a doctoral fellowship from the Council of Scienti?c and Industrial Research(CSIR)to carry out this work,while in India.

References

Agarwal,R.,Gotman,J.,Flanagan,D.,Rosenblat,B.,1996.Auto-matic EEG analysis during long term monitoring in the ICU.Clin.

Electroencephalogr.Neurophysiol.107,44—58.

Akselrod,S.,Gordon,D.,Ubel,F.A.,Shannon,D.C.,Berger,A.C., Cohen,R.J.,1981.Power spectrum analysis of heart rate?uc-tuation:a quantitative probe of beat-to-beat cardiovascular control.Science213(4504),220—222.

Ansakorpi,H.,Korpelainen,J.T.,Huikuri,H.V.,T olonen,U.,Myl-lyla,V.,Isojarvi,J.I.T.,2002.Heart rate dynamics in refractory and well controlled temporal epilepsy.J.Neurol.Neurosurg.

Psychiatry72,26—30.

Ansakorpi,H.,Korpelainen,J.T.,Huikuri,H.V.,T olonen,U.,Myllyla, V.V.,Isojarvi,J.I.,2000.Interictal cardiovascular autonomic responses in patients with temporal lobe Epilepsy.Epilepsia41, 42—47.

Ansakorpi,H.,Korpelainen,J.T.,T anskanen,P.,2004.Cardiovas-cular regulation and hippocampal sclerosis.Epilepsia45(8), 933—939.

Cechetto,D.F.,2000.Neuropathology and cardiovascular regula-tion.In:Horst,G.J.T.(Ed.),The Nervous System and the Heart.

Humana Press,New Jersey,pp.159—179.

Commission on Classi?cation and T erminology of the International League Against Epilepsy,1989.Proposal for revised classi?cation of epilepsies and epileptic syndromes.Epilepsia30,389—399. Deepak,K.K.,Godbole,S.A.,Kochhar,K.P.,Shah,P.,Kochupillai, N.,1996.Autonomic dysfunction and peripheral vasodilatory response in diabetes.Indian J.Physiol.Pharmacol.40(4), 325—329.

Devinsky,O.,2004.Effects of seizures on autonomic and cardiovas-cular function.Epilepsy Curr.4(2),43—46.

Devinsky,O.,Pacia,S.,T atambhotla,G.,1997.Bradycardia and asystole induced by partial seizures:a case report and literature review.Neurology48(6),1712—1714.

Devinsky,O.,Perrine,K.,Theodore,W.H.,1994.Interictal auto-nomic nervous systems function in patients with epilepsy.

Epilepsia35,199—204.

El-Sayed,H.L.,Kotby,A.A.,T omoum,H.Y.,El-Hadidi,E.S.,Behery, S.E.,El-Ganzory,A.M.,2007.Non-invasive assessment of car-dioregulatory autonomic functions in children with epilepsy.

Acta Neurol.Scand.115(6),377—384.

Epstein,M.A.,Michael,R.,Connor,M.,1992.Cardiac rhythm during temporal lobe seizures.Neurology42,50—53.

Ewing,D.J.,Clarke,B.F.,1982.Diagnosis and management of dia-betic autonomic neuropathy.Br.Med.J.285,916—918. Faustmann,P.M.,Ganz,R.E.,1994.Central cardio-autonomic dis-organization in interictal states of epilepsy detected by phase space analysis.Int.J.Neurosci.78(1—2),43—47.

Ficker,D.M.,So,E.L.,Shen,W.K.,1998.Population-based study of the incidence of sudden unexplained death in epilepsy.Neurol-ogy51(5),1270—1274.Frysinger,R.C.,Engel,J.,Harper,R.M.,1993.Interictal heart rate patterns in partial seizure disorders.Neurology43(10), 2136—2139.

Hamilton,M.,1959.The assessment of anxiety states by rating.Br.

J.Med.Psychol.32,50—55.

Harnod,T.,Yang,C.C.,Hsin,Y.L.,Shieh,K.R.,Wang,P.J.,Kuo,T.B., 2007.Heart rate variability in children with refractory general-ized epilepsy.Seizure,October29[epub ahead of print]. Hilz,M.J.,Devinsky,O.,Doyle,W.,Mauerer,A.,Dütsch,M.,2002.

Decrease of sympathetic cardiovascular modulation after tem-poral lobe epilepsy surgery.Brain125(5),985—995.

Isojarvi,J.I.,Ansakorpi,H.,Suominen,K.,et al.,1998.Interictal cardiovascular autonomic responses in patients with epilepsy.

Epilepsia39(4),420—426.

Kanter,R.K.,Strauss,J.A.,Sauro,M.D.,1995.Seizure-induced c-fos expression in rat medulla oblongata is not dependent on associ-ated elevation of blood pressure.Neurosci.Lett.194,201—204. King,D.,Bronen,R.A.,Spencer,D.D.,Spencer,S.S.,1997.T opo-graphic distribution of seizure onset and hippocampal atrophy: relationship between MRI and depth EEG.Electroencephalogr.

Clin Neurophysiol.103(6),692—697.

Leestma,J.E.,Annegers,J.F.,Brodie,M.J.,et al.,1997.Sudden un-explained death in epilepsy:observations from a large clinical development program.Epilepsia38,47—55.

Leutmezer,F.,Schernthaner,C.,Lurger,S.,2003.Electrocardio-graphic changes at the onset of epileptic seizures.Epilepsia44

(3),348—354.

Massetani,R.,Strata,G.,Galli,R.,Gori,S.,Gneri,C.,Limbruno, U.,1997.Alteration of cardiac function in patients with temporal lobe epilepsy:different role of EEG-ECG monitoring and spectral analysis of RR variability.Epilepsia38,363—369.

Nashef,L.,Walker,F.,Allen,P.,Sander,J.W.,Shorvon,S.D.,Fish,

D.R.,1996.Apnoea and bradycardia during epileptic seizures:

relation to sudden death in epilepsy.J.Neurol.Neurosurg.Psy-chiatry60(3),297—300.

Nashef,L.,Garner,S.,Sander,J.W.A.S.,Fish,D.R.,Shorovan,S.D., 1998.Circumsances of death in sudden unexplained death in epilepsy:interviews of beraved relatives.J.Neurol.Neurosurg.

Psychiatry64,349—352.

Nilsson,L.,Bergman,U.,Diwan,V.,Farahmand,B.Y.,Persson,P.G., T omson,T.,2001.Antiepileptic drug therapy and its manage-ment in sudden unexpected death in epilepsy:a case—control study.Epilepsia42(5),667—673.

Nilsson,L.,Farahmand,B.,Persson,Y.,Thiblin,P.G.,T omsan,T., 1999.Risk factor of sudden unexpected death in epilepsy:a case control https://www.360docs.net/doc/0611674472.html,ncet353,888—893.

Nouri,S.,Marshall, B.,2006.Sudden unexpected death in epilepsy.(Online)(access2008February).Available from url address https://www.360docs.net/doc/0611674472.html,/neuro/topic659.

htm#section~References.

Persson,H.,Ericson,M.,T omson,T.,2003.Carbamazepine affects autonomic cardiac control in patients with newly diagnosed epilepsy.Epilepsy Res.57,69—75.

Persson,H.,Kumlien,E.,Ericson,M.,T omson,T.,et al.,2005.Pre-operative heart rate variability in relation to surgery outcome in refractory epilepsy.Neurology65,1021—1025.

Plotkin, E.I.,Swamy,M.N.S.,1992.Nonlinear signal processing based-on parameter invariant moving average modeling.In: https://www.360docs.net/doc/0611674472.html,ECE21,pp.TM3.11.1—TM3.11.4.

Radhakrishnan,K.,1999.Medically refractory epilepsy.In:Rad-hakrishnan,K.(Ed.),Sree Chitra Tirunal Institute for Medical Sciences and T echnology.Trivandrum,pp.8—9.

Rocamora,R.,Kurthen,M.,Lickfett,L.,Von Oertzen,J.,Elger,C.E., 2003.Cardiac asystole in epilepsy:clinical and neurophysiologic features.Epilepsia44(2),179.

Ronkainen, E.,Korpelainen,J.T.,Heikkinen, E.,Myllyl?,V.V., Huikuri,H.V.,Isoj?rvi,J.I.,2006.Cardiac autonomic control in patients with refractory epilepsy before and during vagus nerve

Cardiovascular autonomic functions269

stimulation treatment:a one-year follow-up study.Epilepsia47 (March(3)),556—562.

Sathyaprabha,T.N.,Satishchandra,P.,Netravathi,K.,Sinha,S., Thennarasu,K.,Raju,T.R.,2006.Cardiac autonomic dysfunction in chronic refractory epilepsy.Epilepsy Res.72(1),49—56. Snaith,R.P.,Baugh,S.J.,Clayden,A.D.,Husain,A.,Sipple,M.A., 1982.The Clinical Anxiety Scale:an instrument derived from the Hamilton Anxiety Scale.Br.J.Psychiatry141,518—523.

T ask Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology,1996.Heart rate variability:standards of measurement,physiological inter-pretation,and clinical use.Circulation93,1043—1065.

T omson,T.,Ericson,M.,Iihrman,C.,Lindblad,L.E.,1998.Heart rate variability in patients with epilepsy.Epilepsy Res.30(1), 77—83.Tyrer,P.,Owen,R.T.,Cicchetti,D.,1984.Brief Scale for Anxiety:

a subdivision of the Comprehensive Psychopathological Rating

Scale.J.Neurol.Psychiatry47,970—975.

Walczak,T.,2003.Do antiepileptic drugs play a role in sudden unex-pected death in epilepsy?Drug Saf.26(10),673—683(review). Walczak,T.S.,Leppik,I.E.,D’Amelio,M.,Ruggles,K.,Cascino,G.D., Annegers,J.F.,Hauser,W.A.,2001.Incidence and Risk factors in sudden unexpected death in epilepsy:a prospective cohort study.Neurology56,519—525.

Yadav,R.,Agarwal,R.,Swamy,M.N.S.,2007.STFT-based segmenta-tion in model-based seizure detection.Electrical and Computer Engineering,CCECE Canadian Conference on April22—26,pp.

729—732.

Windows平台上NCL的安装

图文详解Windows平台上NCL的安装 NCL在Linux下的安装非常容易,只需下载适当版本的文件,设置好环境变量即可使用。 NCL在Windows下的安装则要麻烦一些,需要先安装一个虚拟Linux环境(Cygwin/X)。 以下内容详细介绍NCL在Windows平台上的安装过程,希望仅具备Windows基本操作技能的用户也能轻松安装NCL。 一、NCL简介 二、准备工作 三、安装Cygwin/X 四、熟悉Cygwin/X环境 五、安装NCL 六、运行NCL范例 七、语法高亮显示(此部分供有兴趣的用户参考) 八、.hluresfile文件(此部分供有兴趣的用户参考) 九、FAQ 十、获取帮助 一、NCL简介 NCL(NCAR Command Language)是由NCAR的“Computational & Information Systems Laboratory”开发的。 NCL是一种编程语言,专门用于分析和可视化数据。主要用于以下三个领域: 文件输入/输出(File input and output): 资料处理(Data processing): 图形显示(Graphical display):可生出出版级别的黑白、灰度或彩色图。 从5.0起,NCL和NCAR Graphics已经打包在一起发行。2009年3月4日,NCL发布了最新的5.1.0版,该版本更新了地图投影,修正了一些bug,增加了更多的函数及资源。下图为新增的含中国省界的地图(见图1-1)。

二、准备工作 2.1 安装环境 安装环境为WinXP Professional SP3,并做如下假定: 计算机名:TEAM 用户名:Grissom 安装目录:D:\download 用户在实际安装中,请根据自己系统的信息替换本教程中的计算机名和用户名。 特别说明:用户名中不能出现空格,否则会在使用中出现一些问题。 2.2 下载Cygwin/X Cygwin/X=Cygwin+X。通俗地说,Cygwin/X可以在Windows平台上实现命令行+图形的Linux模拟环境。 Cygwin/X的下载与安装非常灵活,用户可根据自己的需求定制。为便于大家的安装,我已下载了安装NCL所需的软件包,包括编译器、编辑器、X Server等,用户可直接从以下地址下载,并解压至D:\download\install 目录下。 Cygwin下载:https://www.360docs.net/doc/0611674472.html,/xglm/2009/2/wnx45afnq7.htm 以下关于Cygwin和Cygwin/X的详细介绍供参考:

ncl源码安装方案

气象项目NCL开发环境配置手册 1建立和测试源码安装ncl所需要的编译环境 1.1安装ncl所需要的编译器 源码编译安装ncl需要C编译器和Fortran编译器。C编译器使用gcc即可。安装ncl5.2.1版本时,最好使用gfortran或g95作为Fortran编译器,而不要使用g77。 1.2为外部软件配置环境变量 例如设置C编译器环境变量,export CC=gcc;设置Fortran编译器,export FC=gfortran。 2下载安装非可选外部软件 注:安装时最好把所有的外部软件都安装到同一根目录下,这样做便于以后告诉ncl编译系统所有的外部软件的安装位置。本文假设所有的外部软件都安装在/usr/local目录下。官网上说如果源码编译安装ncl,则下面的几款软件都是必须安装的: ●JPEG 支持jpeg图形的软件,我下载的jpeg源码安装文件是jpegsrc.v8c.tar.gz。一旦有了源码,执行以下命令进行安装: ./configure --prefix=/usr/local make all install 如果jpeg版本是v6的,则还要额外执行以下命令: make install-lib make install-headers ●zlib 如果想要支持png图形,或者支持grib2数据,则需要下载安装此软件。我下载的zlib源码安装文件是zlib-1.2.5.tar.gz。一旦有了源码,执行以下命令进行安装: ./configure - -prefix=/usr/local make all install ●NetCDF 支持NetCDF数据格式读取的软件包。(如果不需要NetCDF数据读取的话,应该可以 不用安装) - 1-

wrf手册中文

Chapter 1: Overview Introduction The Advanced Research WRF (ARW) modeling system has been in development for the past few years. The current release is Version 3, available since April 2008. The ARW is designed to be a flexible, state-of-the-art atmospheric simulation system that is portable and efficient on available parallel computing platforms. The ARW is suitable for use in a broad range of applications across scales ranging from meters to thousands of kilometers, including: ?Idealized simulations (e.g. LES, convection, baroclinic waves) ?Parameterization research ?Data assimilation research ?Forecast research ?Real-time NWP ?Coupled-model applications ?Teaching 简介 Advanced Research WRF (ARW)模式系统在过去的数年中得到了发展。最近公布了第三版,从2008年4月开始可供使用。ARW是灵活的,最先进的大气模拟系统,它易移植,并且有效的应用于各种操作系统。ARW适用于从米到成千上万公里尺度的各种天气系统的模拟,它的功能包括: ?理想化模拟(如,LES,对流,斜压波) ?参数化研究 ?数据同化研究 ?预报研究 ?实时数值天气预报 ?耦合模式应用 ?教学 The Mesoscale and Microscale Meteorology Division of NCAR is currently maintaining and supporting a subset of the overall WRF code (Version 3) that includes: ?WRF Software Framework (WSF) ?Advanced Research WRF (ARW) dynamic solver, including one-way, two-way nesting and moving nest. ?The WRF Preprocessing System (WPS) ?WRF Variational Data Assimilation (WRF-Var) system which currently supports 3DVAR capability ?Numerous physics packages contributed by WRF partners and the research community ?Several graphics programs and conversion programs for other graphics tools And these are the subjects of this document. The WRF modeling system software is in the public domain and is freely available for community use.

《叉车操作手册》

叉车电瓶和充电器使用规程 一、电瓶: 当叉车配备了其它种类的电瓶及/或充电器时,遵从其制造商的指导。 (一)远离火种(爆炸性气体) 绝对禁止火焰接近电瓶。电瓶内部会产生爆炸性气体;吸烟、火焰及火花,均会引起电瓶爆炸。 (二)小心触电 严禁引起短路,电瓶带有高电压和能量。当处理电瓶时,要戴护目镜、穿胶鞋和戴橡皮手套。 (三)正确接触 严禁将电瓶的正、负极调乱,否则可导致火花、燃烧及/或爆炸。 (四)远离工具 严禁让工具接近电瓶两极,以免引起火花或短路。 (五)勿过量放电 严禁让叉车的电量耗至叉车不能移动时,才进行充电。(会引致电池寿命缩短)当电瓶负荷显示器显示无电时,请立刻进行充电。 (六)保持清洁 保持电瓶上表面干净。严禁使用干布擦电瓶表面,以免引起静电。清洁电瓶要戴护目镜、穿胶鞋和戴橡皮手套。当清洁电瓶后,才能进行充电。 (七)穿着安全服 为了个人安全,需配戴护目镜、穿胶鞋和戴橡皮手套。 (八)小心电瓶电解液。 电瓶电解液含有硫酸,严禁让皮肤接触电瓶电解液。 (九)急救 电瓶电解液含有硫酸,若与之接触可能造成烧伤。发生意外时,请立即进行急救并请医生治理。 ①溅到皮肤上:用水冲洗10-15分钟 ②溅到眼睛上:用水冲洗10-15分钟 ③误咽:喝大量的水和牛奶 ④溅到衣服上:立即脱下衣服 如不遵守以上各点,可造成严重的伤亡事故。 (十)拧紧电瓶通风盖 拧紧电瓶通风盖,以防泄漏电解液。 (十一)清洗 严禁在叉车上清洗电瓶,以免损坏叉车。 (十二)不正常的电瓶 如电瓶发生下列情况,与和资格的服务机构或电瓶生产商联系。 ①电瓶发臭 ②电解液变浊 ③电解液减少速度过快 ④电解液温度过高 (十三)严禁拆解电瓶 不得让电解液耗尽、拆卸或自行维修电瓶。

WRFChem安装及使用说明手册

WRF-Chem安装及使用说明手册 V1.0 编写者:王彬 2015年6月

目录 1. 引言 (3) 1.1 编写目的 (3) 1.2 背景 (3) 1.3 参考资料 (4) 2. 安装过程 (4) 2.1 设定环境变量 (4) 2.2 WRFV3安装 (5) 2.3 WPS与WRFDA的安装 (6) 3. 使用过程 (6) 3.1 WPS数据准备说明 (7) 3.2 气象初始场的准备说明 (8) 3.3 化学数据前处理程序的使用说明 (8) 3.4 化学数据转化程序的使用说明 (9) 附录1 (prep_chem_sources.inp) (14) 附录2(ncl程序) (18) 附录3(convert.f90) (19)

1. 引言 1.1 编写目的 本手册为指导WRF-Chem数值模拟的用户,方便轻松掌握WRF-Chem数值模式的安装及使用而编写。希望该手册在大家使用和学习过程中起到引导和帮助的作用。 1.2 背景 WRF-Chem模式是由国家大气研究中心(NCAR)等机构联合开发的新一代大气预报模式,真正实现了气象模式与化学传输模式在时空上的耦合。它不仅能够模拟污染气体和气溶胶的排放、传输以及混合过程,还可用于分析空气质量、云与化学之间的相互作用等。研究表明,WRF-Chem对气象场以及污染物的模拟表现出值得信赖的能力。 WRF-Chem在原有WRF模式的基础上耦合了化学反应过程,它通过在WRF 的辐射方案中引入气溶胶光学厚度、单次散射反照率和不对称因子表现气溶胶的直接辐射效应。此外,还增加了云滴数浓度的计算,这会改变原有WRF辐射方案中云粒子有效半径的计算方式,从而影响云的反照率,体现气溶胶的Twomey 效应。另一方面,Liu et al.提出了以云滴数浓度为阈值的新的云水向雨水自动转换参数化方案,取代了原有的Kessler方案,体现气溶胶的Albrecht效应。

小型机UNIX系统操作指南完整版

小型机UNIX系统操作指南 一、 UNIX基本指令 1、Ls –l/-a/-R 列目录 2、Cd 更改目录 3、ps –ef |grep ora_ 看进程 4、kill -9 pid 杀进程 5、more filename 按屏看文本 6、cat filename 看文本 7、strings filename 看文本 8、df 看文件系统 9、du –k 看空间 10、rm 删文件 11、rm –r dir 删目录 12、find . –name filename 查找文件 13、cp *.* /aaa 拷贝文件 14、mv 移动文件 15、tail –f file1 看文件尾,可临控文件变化 16、makedir 建目录 17、id 看用户 18、mount /cdrom 19、>file1 20、set –o vi 可保存历史命令 21、su – user 切换用户 22、passwd 改密码 23、man 查帮助 24、ifconfig 看网卡状态 25、date 看时间

26、chmod 改权限 27、chown 改组/用户 28、vi 编辑器,常用的操作 二、 AIX (一)、文件系统 1、VG、PV、LV、LP、PP的概念及关系 2、基本文件系统 root(/) :home用户、usr软件、tmp临时、var控制管理文件(二)、常用指令 1、lsdev –C 看设备 2、info 相关书籍 3、lslpp –l 安装的软件 4、clstat 监控群集状态 5、errpt –a|more 错误日志 6、errclear 0 删除错误日志 7、df –k 看文件系统空间 8、ps –aux 列出当前进程 9、lspv –o 看激活的VG 10、smitty mkgroup\group\rmgroup 对组操作 hacmp 对群集操作 user\mkuser\rmuser 对用户操作 chinet 改IP tcpip 网络配置 11、varyonvg sharedvg 挂VG varyoffvg sharedvgb 卸VG 12、diag 故障诊断 13、cfgmgr –v 重新配置硬件 14、netstat –in 看网卡信息 15、lsvg –p 看VG (二)、系统开、关机

心血管系统杂志名全称和规范缩写_来源于SCI_1_

心血管系统杂志名全称和规范缩写(来源于SCI )(1) 杂志名称 标准缩写 Acta Cardiologica Acta Cardiol American Heart Ho spital Journal Am Heart Ho sp J American Heart Journal Am Heart J American Journal of Cardiovascular Drugs Am J Cardiovasc Drugs American Journal of Geriatric Cardiology Am J Geriatr Cardiol American Journal of Hypertension Am J Hypertens American Journal of Physiology 2Heart and Circulatory Physiology Am J Physiol Heart Circ Physiol Angiology Angiology Annals of Noninvasive Elect rocardiology Ann Noninvasive Elect rocardiol Annals of Vascular Surgery Ann Vasc Surg Arteriosclero sis ,Thrombo sis ,and Vascular Biology Arterioscler Thromb Vasc Biol At hero sclerosis At hero sclero sis At hero sclerosis Supplement s At hero scler Suppl Basic Research in Cardiology Basic Res Cardiol Blood Coagulatio n and Fibrinolysis Blood Coagul Fibrinolysis Blood Pressure Blood Press Blood Pressure Monitoring Blood Press Monit Canadian Jo urnal of Cardiology Can J Cardiol Cardiac Elect rop hysiology Review Card Elect rop hysiol Rev Cardiology Cardiology Cardiology Clinics Cardiol Clin Cardiology in Review Cardiol Rev Cardiology in t he Y oung Cardiol Y oung CardioVascular and Interventional Radiology Cardiovasc Intervent Radiol Cardiovascular drug reviews Cardiovasc Drug Rev Cardiovascular Drugs &Therapy Cardiovasc Drugs Ther Cardiovascular Radiation Medicine Cardiovasc Radiat Med Cardiovascular Research Cardiovasc Res Cardiovascular Revascularization Medicine Cardiovasc Revasc Med Cardiovascular Surgery Cardiovasc Surg Cat heterization and Cardiovascular Interventions Cat heter Cardiovasc Interv Circulatio n Circulation Circulatio n Journal Cir J Circulatio n Research Cir Res Clinical &Applied Thrombo sis/Hemostasis Clin Appl Thromb Hemost Clinical and Experimenual Hypertension Clin Exp Hypertens Clinical Cardiology Clin Cardiol Clinical Research in Cardiology Clin Res Cardiol (待续) ? Ⅳ?

无锡明慈心血管病医院WuxiMingciCardiovascularHospital

无锡明慈心血管病医院Wuxi Mingci Cardiovascular Hospital Ein zukünftiges erstklassiges Herzzentrum

1 2 3 4 医院特色 四大特色 Vier Besonderheiten 中德国际合作 Deutsch-Chinesische Zusammenarbeit 一流硬件设施 Hervorragende Ausrüstung 顶尖专家团队 Ein gutes Medizinteam 绿色人文服务 Menschliches Service Besonderheiten

医院特色理念 国际化:与德国北威州心脏和糖尿病中心深度合作,引进国际化管理流程、机制和理念,以优质、高效的医疗水平服务患者Internationalisierung: -Tiefe Kooperation mit Herz- und Diabeteszentrum Nordrhein-Westfalen (NDZ NRW) -übernahme von effizientem Manageentskonzept, Struktur und Prozess, um Patienten mit hocher Qualit?t und Leistungen zu versorgen. 产业化:集预防、诊断、治疗、康复保健、健康管理为一体。 Industrialisierung: Integration von Pr?vention, Diagnostik, Behandlung, Rehabilitation und Gesundheitsmanagement 人性化:我们始终把患者利益置于首位,为患者提供他们真正需要的、有价值的医疗服务。 Menschliche Anliegen: Der Patient steht immer im Mittelpunkt aller Bemühungen Unsere Philosophien

11.3.4盆部和下肢的动脉

Systematic anatomy-cardiovascular system

Systematic anatomy-cardiovascular system髂总动脉Common iliac artery z第4腰椎水平续自腹主动脉 z沿腰大肌内侧下至骶髂关节 处分为髂内动脉和髂外动脉 腹主动脉 髂总动脉 髂外动脉 髂内动脉

Systematic anatomy -cardiovascular system 髂内动脉internal iliac A. z 壁支–闭孔动脉obturator a. –臀上动脉sup. gluteal a.–臀下动脉inf. gluteal a. –髂腰动脉iliolumbar a. –骶外侧动脉lateral sacral a.右髂外动脉髂内动脉 臀上动脉 臀下动脉膀胱上动脉 骶外侧动脉 髂腰动脉

Systematic anatomy -cardiovascular system 髂内动脉internal iliac A.z 髂内动脉 internal iliac A.–脏支: ?脐动脉umblic a.?子宫动脉uterine a.?阴部内动脉internal pudendal a.?膀胱下动脉Inf. vesical a. ?直肠下动脉Inf. rectal a.右髂总动脉髂外动静脉髂内动脉 阴部内动脉直肠下动脉子宫动脉膀胱上动脉脐动脉膀胱下动脉

Systematic anatomy-cardiovascular system髂内动脉internal iliac A. z子宫动脉uterine a. :沿盆腔侧壁下行,进入子宫阔韧带底部两层腹膜之间,在子宫颈外侧约2cm处从输尿管ureter前上方跨过,再沿子宫侧缘迂曲上升至子宫底。子宫动脉分支营养子宫uterus 、阴道、输卵管和卵巢,并与卵巢动脉吻合 桥下流水子宫动脉 输尿管

ISO 8637-2010Cardiovascular implants and extracorporeal systems 血液透析器、滤过器、血液过滤器

Reference number ISO 8637:2010(E) ? ISO 2010 INTERNATIONAL STANDARD ISO 8637 Third edition 2010-07-01 Cardiovascular implants and extracorporeal systems — Haemodialysers, haemodiafilters, haemofilters and haemoconcentrators Implants cardiovasculaires et systèmes extracorporels — Hémodialyseurs, hémodiafiltres, hémofiltres et hémoconcentrateurs Copyright International Organization for Standardization --`,,```,,,,````-`-`,,`,,`,`,,`---

ISO 8637:2010(E) PDF disclaimer This PDF file may contain embedded typefaces. In accordance with Adobe's licensing policy, this file may be printed or viewed but shall not be edited unless the typefaces which are embedded are licensed to and installed on the computer performing the editing. In downloading this file, parties accept therein the responsibility of not infringing Adobe's licensing policy. The ISO Central Secretariat accepts no liability in this area. Adobe is a trademark of Adobe Systems Incorporated. Details of the software products used to create this PDF file can be found in the General Info relative to the file; the PDF-creation parameters were optimized for printing. Every care has been taken to ensure that the file is suitable for use by ISO member bodies. In the unlikely event that a problem relating to it is found, please inform the Central Secretariat at the address given below. COPYRIGHT PROTECTED DOCUMENT ? ISO 2010 All rights reserved. Unless otherwise specified, no part of this publication may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying and microfilm, without permission in writing from either ISO at the address below or ISO's member body in the country of the requester. ISO copyright office Case postale 56 ? CH-1211 Geneva 20 Tel. + 41 22 749 01 11 Fax + 41 22 749 09 47 E-mail copyright@https://www.360docs.net/doc/0611674472.html, Web https://www.360docs.net/doc/0611674472.html, Published in Switzerland ii ? ISO 2010 – All rights reserved Copyright International Organization for Standardization --`,,```,,,,````-`-`,,`,,`,`,,`---

用NCL处理卫星数据(一个简单的教程)

用NCL处理卫星数据(一个简单的教程) 2010年03月19日星期五15:13 这个教程主要介绍如何用NCL读取卫星数据,如何将数据存储为二进制格式,如何作图。 本教程所用的数据:https://www.360docs.net/doc/0611674472.html,/file/f19ba404fc 这个数据是AMSR-E的L2A产品,更多信息请查阅相关文档。 在开始这个教程前,请确认已经安装好了NCL。 1. 运行NCL 和GrADS类似,NCL也可以运行在交互式环境中,即输入一条命令执行一条命令。 交互式环境使用: 在命令行下输入 $ ncl 退出请输入命令 ncl 0> exit 交互式环境不方便重复操作,一旦退出程序就需要全部重新来过,所以推荐编写NCL脚本。一个NCL脚本主要包括以下几个部分: load 外部函数 begin ;命令和操作 end load用来载入外部函数。 文件操作、数据操作、数据可视化等代码都放在load 语句之后。 半角分号“;”后的内容是注释,NCL只有行注释功能。 begin 和end 可有可无,但如果出现了begin,就必须有end 与之对应。 NCL脚本扩展名为.ncl。比如有一NCL脚本文件为script.ncl,运行时可以用下面的方法:$ ncl < script.ncl 或$ ncl script.ncl

下面来写一个简单的NCL脚本。打开vi之类的编辑软件,将下面的内容复制进去,然后保存到卫星数据文件所 ;******************************************************** ; Load NCL scripts load "$NCARG_ROOT/lib/ncarg/nclscripts/csm/gsn_code.ncl" load "$NCARG_ROOT/lib/ncarg/nclscripts/csm/gsn_csm.ncl" load "$NCARG_ROOT/lib/ncarg/nclscripts/csm/contributed.ncl" load "$NCARG_ROOT/lib/ncarg/nclscripts/csm/shea_util.ncl" load "$NCARG_ROOT/lib/ncarg/nclscripts/csm/skewt_func.ncl" load "$NCARG_ROOT/lib/ncarg/nclscripts/csm/wind_rose.ncl" ; load语句载入了NCL常用的几个外部程序,建议以后自己写脚本时也保留这6行的内容。 ;******************************************************** begin fi = addfile("./AMSR_E_L2A.hdf","r") print(fi) end 运行这个脚本 $ ncl test.ncl > log 2. 熟悉数据 打开log文件 从第11行相关信息可以知道该文件为HDFEOS_V2.5 第663行开始可以得知该卫星数据的生成时间等信息 第957行开始是卫星数据的维度信息(dimensions) 第983行起是变量信息(variables) 这些对文件内容进行描述的信息被称作元数据(metadata),元数据对于数据的存储和发布很重要。它记录了数据以及数据集开发的历史等。 3. 读取数据 下面以89V的数据为例 89V的元数据为: short89_0V_Res_1_TB__4 ( DataTrack_lo_Low_Res_Swath, DataXTrack_lo_Low_Res_Swath ) SCALE_FACTOR : 0.01 OFFSET : 327.68 UNIT : Kelvin hdf_name : 89.0V_Res.1_TB hdf_group : Low_Res_Swath/Data Fields hdf_group_id : 4

相关文档
最新文档